Quarterly Institutional Activity in SLRX

Shares Bought
Shares Sold
View Transactions

Top Institutions Holding SLRX

View all

Latest Institutional Activity in SLRX

Top Purchases

Q3 2022
Renaissance Technologies LLC Shares Held: 634K ($951K)
Q3 2022
Horizon Kinetics Asset Management LLC Shares Held: 60K ($90K)
Q3 2022
Morgan Stanley Shares Held: 1.5K ($2.25K)
Q3 2022
Concourse Financial Group Securities, Inc. Shares Held: 0 ($0)
Q2 2022
Virtu Financial LLC Shares Held: 82.2K ($123K)

Top Sells

Q3 2022
Vanguard Group Inc Shares Held: 1.35M ($2.03M)
Q3 2022
Millennium Management LLC Shares Held: 116K ($174K)
Q3 2022
Tower Research Capital LLC (Trc) Shares Held: 24.1K ($36.1K)
Q3 2022
Two Sigma Securities, LLC Shares Held: 12.2K ($18.3K)
Q3 2022
Ubs Group Ag Shares Held: 40.8K ($61.3K)

About SLRX

Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a small molecular protein degrader for the treatment of hematological and solid tumors. It has a strategic partnership with The University of Utah Research Foundation for the exclusive license with respect to patent rights protecting SP-2577 and related compounds; HLB Life Sciences to develop, produce, manufacture, use, and sell the drug in South Korea; and Cancer Prevention and Research Institute of Texas for product development activities, as well as a research partnership with the Cancer Epigenetics Institute at Fox Chase Cancer Center to identify new indications and biomarkers for SP-2577. The company is headquartered in Houston, Texas.


Insider Transactions at SLRX

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
0 Shares
From 0 Insiders
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on SLRX

Follow Salarius Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SLRX shares.

Notify only if

Insider Trading

Get notified when an Salarius Pharmaceuticals, Inc. insider buys or sells SLRX shares.

Notify only if

News

Receive news related to Salarius Pharmaceuticals, Inc.

Track Activities on SLRX